https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-01 / Curr Drug Targets 2006 Oct;7(10):1371-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-01 / Curr Drug Targets 2006 Oct;7(10):1371-42006-10-01 00:00:002019-02-15 08:51:26Current status of immunotherapy in B cell malignancies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-09-05 / J. Clin. Endocrinol. Metab. 2006 Nov;91(11):4571-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-09-05 / J. Clin. Endocrinol. Metab. 2006 Nov;91(11):4571-72006-09-05 00:00:002019-02-15 08:53:27Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-09-01 / J Zhejiang Univ Sci B 2006 Sep;7(9):719-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-09-01 / J Zhejiang Univ Sci B 2006 Sep;7(9):719-242006-09-01 00:00:002024-08-26 09:28:19Successful immunological treatment of gallbladder cancer in India–case report
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-09-01 / Endocr. Relat. Cancer 2006 Sep;13(3):779-95
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-09-01 / Endocr. Relat. Cancer 2006 Sep;13(3):779-952006-09-01 00:00:002019-02-15 08:53:27Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-09-01 / Int. Rev. Immunol. 2006 Sep-Dec;25(5-6):377-413
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-09-01 / Int. Rev. Immunol. 2006 Sep-Dec;25(5-6):377-4132006-09-01 00:00:002019-02-15 08:45:17Dendritic cell-based immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-08-16 / J Transl Med 2006 Aug;4:36
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-08-16 / J Transl Med 2006 Aug;4:362006-08-16 00:00:002019-02-15 08:49:33Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-25 / Gene Ther. 2006 Oct;13(19):1391-402
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-25 / Gene Ther. 2006 Oct;13(19):1391-4022006-05-25 00:00:002019-02-15 08:50:22HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-12 / Cancer Immunol. Immunother. 2006 Nov;55(11):1420-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-12 / Cancer Immunol. Immunother. 2006 Nov;55(11):1420-52006-05-12 00:00:002019-02-15 08:44:40Virology- and immunology-based gene therapy for cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-04 / Sao Paulo Med J 2006 May;124(3):161-2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-04 / Sao Paulo Med J 2006 May;124(3):161-22006-05-04 00:00:002024-12-03 08:04:16Pure sarcomatous recurrence of clear cell renal carcinoma following radical nephrectomy and dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-01 / Clin. Cancer Res. 2006 May;12(9):2817-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-01 / Clin. Cancer Res. 2006 May;12(9):2817-252006-05-01 00:00:002006-05-01 00:00:00A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides
